Identification of associations and distinguishing moyamoya disease from ischemic strokes of other etiologies: A retrospective case-control study.

Autor:	Sutton CXY; University of Hawai'i at Mānoa, John A. Burns School of Medicine, Honolulu, HI, USA., Carrazana E; University of Hawai'i at Mānoa, John A. Burns School of Medicine, Honolulu, HI, USA.; Hawai'i Pacific Neuroscience, Brain Research, Innovation and Translation Lab, Honolulu, HI, USA., Mitchell C; Hawai'i Pacific Neuroscience, Brain Research, Innovation and Translation Lab, Honolulu, HI, USA., Viereck J; University of Hawai'i at Mānoa, John A. Burns School of Medicine, Honolulu, HI, USA.; Hawai'i Pacific Neuroscience, Brain Research, Innovation and Translation Lab, Honolulu, HI, USA., Liow KK; University of Hawai'i at Mānoa, John A. Burns School of Medicine, Honolulu, HI, USA.; Hawai'i Pacific Neuroscience, Brain Research, Innovation and Translation Lab, Honolulu, HI, USA., Ghaffari-Rafi A; University of Hawai'i at Mānoa, John A. Burns School of Medicine, Honolulu, HI, USA.; University of California Davis, School of Medicine, Department of Neurological Surgery, Sacramento, CA, USA.
Jazyk:	angličtina
Zdroj:	Annals of medicine and surgery (2012) [Ann Med Surg (Lond)] 2022 May 11; Vol. 78, pp. 103771. Date of Electronic Publication: 2022 May 11 (Print Publication: 2022).
DOI:	10.1016/j.amsu.2022.103771
Abstrakt:	Introduction: Better characterizing moyamoya disease (MMD) from ischemic strokes of other etiologies may facilitate earlier diagnosis by raising suspicion for a diagnostic work-up. Methods: To identify associated variables, MMD cases (n = 12) were compared against three sets of controls: age-, sex-, and race-matched controls of patients with general neurological disorders (n = 48), unmatched general controls (n = 48), and unmatched non-MMD ischemic stroke controls (n = 48). Results: MMD patients were 32 years (p < 0.0001) younger than ischemic stroke controls. Relative to non-MMD ischemic strokes, MMD patients had greater odds of presenting with visual field defects (OR: 9.13, p = 0.09) or dizziness (OR: 9.13, p = 0.09), as well as being female (OR: 8.04, p = 0.008), Asian (OR: 3.68, p = 0.087), employed (OR: 6.96, p = 0.02), having migraines (OR: 21.61, p = 0.005), epilepsy (OR: 6.69, p = 0.01), insomnia (OR: 8.90, p = 0.099), and a lower Charlson Comorbidity Index (CCI; p = 0.002). Patients with MMD, compared to non-MMD ischemic strokes, also had a 4.67 kg/ m 2 greater body mass index (BMI) and larger odds (OR relative to normal BMI: 21.00, p = 0.03) of being from obesity class III (>40 kg/ m 2 ), yet reduced odds of coronary artery disease (OR: 0.13, p = 0.02). Relative to general controls, MMD patients had greater odds of diabetes mellitus type 2 (OR: 10.07, p = 0.006) and hypertension (OR: 7.28, p = 0.004). Conclusion: MMD not only has a unique clinical presentation from other ischemic strokes, but also unique comorbidities, which may facilitate earlier work-up and treatment. Competing Interests: None. (© 2022 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu